임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 중단 (진행 중)· Multiple MyelomaNivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel
협력: BMS
- 2상모집 중단 (진행 중)· Locally Advanced Breast CancerSafety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
리드: 바이오엔테크 · 협력: BMS
- 2상모집 중단 (진행 중)· Metastatic Renal Cell CarcinomaA Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)
협력: BMS
- 2상모집 중단 (진행 중)· Alzheimer Disease, Early OnsetStudy to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
리드: BMS
- 2상모집 중단 (진행 중)· Follicular LymphomaPhase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
협력: BMS
- 2상모집 중단 (진행 중)· Urologic NeoplasmsStage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
협력: BMS
- 2상모집 중단 (진행 중)· Pancreatic Ductal AdenocarcinomaAnti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Follicular Lymphoma Stage IITreatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.
협력: BMS
- 2상모집 중단 (진행 중)· Stage II MelanomaA Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma
협력: BMS
- 2상모집 중단 (진행 중)· Myelodysplastic SyndromesLuspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
협력: BMS
- 2상모집 중단 (진행 중)· Castration-resistant Prostate CancerStudy of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Resectable Stage IIA to IIIB Non-small Cell Lung CancerAn Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Leukemia, Myeloid, AcuteAn Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission
리드: BMS
- 2상모집 중단 (진행 중)· Renal Cell CarcinomaNeoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Urothelial CarcinomaCheckpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC
협력: BMS
- 2상모집 중단 (진행 중)· Renal Cancer MetastaticCLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy
협력: BMS
- 2상모집 중단 (진행 중)· Systemic Lupus ErythematosusA Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
리드: BMS
- 2상모집 중단 (진행 중)· Metastatic Head-and-neck Squamous-cell CarcinomaNab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor
협력: BMS
- 2상모집 중단 (진행 중)· Advanced Biliary Tract CancerCombination Immunotherapy in Rare Cancers Under InvesTigation
협력: BMS
- 2상모집 중단 (진행 중)· Lupus Erythematosus, DiscoidA Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
리드: BMS
- 2상모집 중단 (진행 중)· Colorectal AdenocarcinomaStudy of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Metastatic Prostate Neuroendocrine CarcinomaA Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Hodgkin LymphomaIpilimumab With or Without Nivolumab in Relapsed/Refractory cHL
협력: BMS
- 2상모집 중단 (진행 중)· Colorectal Cancer MetastaticTwo Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC.
협력: BMS
- 2상모집 중단 (진행 중)· Head and Neck Squamous Cell CarcinomaNeoadjuvant Targeting of Myeloid Cell Populations in Combination With Nivolumab in Head & Neck Ca
협력: BMS
- 2상모집 중단 (진행 중)· Esophagogastric CancerA Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Metastatic Soft-tissue SarcomaCabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
협력: BMS
- 2상모집 중단 (진행 중)· Papillary Renal Cell CarcinomaCabozantinib In Combo With NIVO + IPI In Advanced NCCRCC
협력: BMS
- 2상모집 중단 (진행 중)· LeiomyosarcomaA Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
협력: BMS
- 2상모집 중단 (진행 중)· Non Small Cell Lung CancerNivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC
협력: BMS, 일라이 릴리
- 2상모집 중단 (진행 중)· Metastatic Microsatellite Stable Colorectal CancerNivolumab+Ipilimumab+RT in MSS mCRC
협력: BMS
- 2상모집 중단 (진행 중)· Kidney CancerCYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
협력: BMS
- 2상모집 중단 (진행 중)· Pancreatic CancerNivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Hormone Sensitive Prostate CancerNivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
협력: BMS
- 2상모집 중단 (진행 중)· Esophageal Squamous Cell CarcinomaTrial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.
협력: BMS
- 2상모집 중단 (진행 중)· Metastatic Renal Cell CarcinomaSBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Head and Neck Squamous Cell Carcinoma (HNSCC)Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Breast CancerPeri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Solid TumorStudy of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
협력: BMS
- 2상모집 중단 (진행 중)· Localized Oesogastric AdenocarcimonaPre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.
협력: BMS
- 2상모집 중단 (진행 중)· MesotheliomaNeoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
협력: BMS
- 2상모집 중단 (진행 중)· Endometrial AdenocarcinomaStudy of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment
협력: BMS
- 2상모집 중단 (진행 중)· Graft Versus Host DiseaseAcute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
협력: BMS
- 2상모집 중단 (진행 중)· Non Small Cell Lung CancerA Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China
협력: BMS
- 2상모집 중단 (진행 중)· Gastroesophageal AdenocarcinomaPhase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
협력: BMS
- 2상모집 중단 (진행 중)· Rectal CancerTrial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients
협력: BMS
- 2상모집 중단 (진행 중)· Breast Neoplasm FemaleNivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients
협력: BMS
- 2상모집 중단 (진행 중)· Breast CancerNIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Bronchial DysplasiaNivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers
협력: BMS
- 2상모집 중단 (진행 중)· Aggressive Non-Hodgkin LymphomaNivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
협력: BMS
- 2상모집 중단 (진행 중)· Grade I Neuroendocrine CarcinomaNivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
협력: BMS
- 2상모집 중단 (진행 중)· Small Cell Lung CancerIpilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy
협력: BMS
- 2상모집 중단 (진행 중)· Refractory MSI - H Solid Tumors Prior of PD-(L) 1 TherapyStudy of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor
협력: BMS
- 2상모집 중단 (진행 중)· Prostate CancerNivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer
협력: BMS
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.